This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2025 Jun 1;185(6):679.

doi: 10.1001/jamainternmed.2025.0651.

Secondary Prevention of Medication-Related Harms

Timothy S Anderson^{1

2}

Affiliations

Affiliations

¹ Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
² Associate Editor, JAMA Internal Medicine.

PMID: 40293737
DOI: 10.1001/jamainternmed.2025.0651

Secondary Prevention of Medication-Related Harms

Timothy S Anderson. JAMA Intern Med. 2025.

. 2025 Jun 1;185(6):679.

doi: 10.1001/jamainternmed.2025.0651.

Author

Timothy S Anderson^{1

2}

Affiliations

¹ Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
² Associate Editor, JAMA Internal Medicine.

PMID: 40293737
DOI: 10.1001/jamainternmed.2025.0651

No abstract available

PubMed Disclaimer

Comment in

Emergency Department Visits for Medication-Related Events With vs Without Pharmacist Intervention: The URGEIM Randomized Clinical Trial.
Villiet M, Laureau M, Perier D, Pinzani V, Giraud I, Lohan L, Bobbia X, Mercier G, Jaussent A, Macioce V, Sebbane M, Faucanié M, Breuker C. Villiet M, et al. JAMA Intern Med. 2025 Jun 1;185(6):669-678. doi: 10.1001/jamainternmed.2025.0640. JAMA Intern Med. 2025. PMID: 40293767 Clinical Trial.

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems